Live feed08:01:00·171dPRReleasevia QuantisnowTransition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal DementiaByQuantisnow·Wall Street's wire, on your screen.VYGR· Voyager Therapeutics Inc.Health Care
